Scarica l'app Stockscreener
1.29
5.15%
-0.07
Dopo l'orario di chiusura:
1.36
0.07
+5.43%
Precedente Chiudi:
$1.36
Aprire:
$1.35
Volume 24 ore:
29,974
Relative Volume:
0.40
Capitalizzazione di mercato:
$3.73M
Reddito:
$142.00K
Utile/perdita netta:
$-1.23M
Rapporto P/E:
2.77
EPS:
0.4657
Flusso di cassa netto:
$-10.62M
1 W Prestazione:
+0.00%
1M Prestazione:
-11.64%
6M Prestazione:
-41.10%
1 anno Prestazione:
-34.85%
Intervallo 1D:
$1.29
$1.3516
Intervallo di 1 settimana:
$1.22
$1.375
Portata 52W:
$1.22
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Nome
Vivosim Labs Inc
Settore
Industria
Telefono
858-224-1000
Indirizzo
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
1.29 | 3.94M | 142.00K | -1.23M | -10.62M | 0.4657 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-12-13 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | Iniziato | Raymond James | Outperform |
| 2015-08-11 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | Iniziato | Jefferies | Buy |
| 2015-06-29 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Vivosim Labs Inc Borsa (VIVS) Ultime notizie
VivoSim Labs Inc. (VIVS) Edges Up 1.49% as It Tests Resistance at $1.43Composite Profile - Newser
VIVS Q3 2025 Earnings: EPS Surprise Beats Estimates Amid Unreported RevenueSocial Signal Watchlist - Newser
VIVS Q4'25 Earnings: EPS estimate is (2.04) USD - TradingView
VIVS Stock Price, Quote & Chart | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VIVS Stock Chart | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
Number of shareholders of VivoSim Labs, Inc. – NASDAQ:VIVS - TradingView
Lobbying Update: $10,000 of VIVOSIM LABS INC. lobbying was just disclosed - Quiver Quantitative
VivoSim Labs, Inc. (VIVS) Eps Diluted (TTM) - Zacks Investment Research
What VivoSim Labs (VIVS) capital allocation tells us | Q3 2025: Better Than ExpectedGuidance Update - newser.com
VivoSim Platform Predicts Gastrointestinal Toxicity - GlobeNewswire
Can AI replace animal tests? VivoSim cites 96% diarrhea accuracy - Stock Titan
VIVS Price Today: VivoSim Labs, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
VIVS VivoSim Labs notches 32.1 percent Q3 2025 revenue growth, shares edge higher on narrower than expected loss.AI Stock Signals - Newser
VivoSim Labs (VIVS) Stock: Is It a Compelling Buy (-4.35%) 2026-04-20Earnings Beat Stocks - Cổng thông tin điện tử Tỉnh Sơn La
VIVS Technical Analysis & ETF Price Forecast - Intellectia AI
Gap Down: Will VivoSim Labs Inc benefit from AI trendsEarnings Trend Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Esousa Group reports 9.9% stake in VivoSim Labs (NASDAQ: VIVS) - Stock Titan
VIVS SEC FilingsVivoSim Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
VivoSim Labs Announces $4 Million Public Offering to Accelerate Adoption of 3D Human Tissue Models for Drug Testing - Minichart
VivoSim Labs Prices Best-Efforts Public Offering - TipRanks
VivoSim Labs Raises ~$2.5M in Initial Tranche; Signs Purchase and Placement Agreements - TradingView
VivoSim Labs (Nasdaq: VIVS) raises $3M in first tranche of $4M deal - Stock Titan
VivoSim Labs (NASDAQ: VIVS) registers 3.51M shares with detachable warrants - Stock Titan
VIVS Stock Analysis: VivoSim Labs Inc gains 13.68 percent to 1.62 amid bullish momentum - Newser
VivoSim Announces Pricing of up to a $4 Million Public Offering - Sahm
VivoSim Labs prices $4 million public offering at $1.14/share By Investing.com - Investing.com Australia
VivoSim Labs prices $4M public offering at $1.14 per share - Investing.com Australia
VivoSim Labs, Inc. (VIVS) stock price, news, quote and history - au.finance.yahoo.com
VivoSim Labs prices $4 million public offering at $1.14/share - Investing.com
[EFFECT] VivoSim Labs, INC. SEC Filing - Stock Titan
VivoSim Labs (NASDAQ: VIVS) outlines $4M two-tranche stock and warrant financing - Stock Titan
Aug Breakouts: Is VivoSim Labs Inc benefiting from innovation trendsWeekly Gains Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
Published on: 2026-03-29 07:44:35 - baoquankhu1.vn
VivoSim Labs (NASDAQ: VIVS) files S-1 for $4M unit offering - Stock Titan
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing - GlobeNewswire
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs - Yahoo Finance
VivoSim Labs, Inc.: Fundamental Analysis and Financial Ratings | 4OR | US68620A3023 - marketscreener.com
Market Catalysts: What is the cash position of VivoSim Labs Inc2026 Price Swings & Reliable Trade Execution Plans - baoquankhu1.vn
Is VivoSim Labs Inc. stock a buy before product launchesJuly 2025 Rallies & Safe Capital Investment Plans - Naître et grandir
Buyback Watch: How much upside does VivoSim Labs Inc haveTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Why Is VIVS Stock Up 79% Today? - Stocktwits
VIVS Earnings History & Surprises | EPS & Revenue Results | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim names Raghunathan as VP of global sales By Investing.com - Investing.com Canada
VivoSim names Raghunathan as VP of global sales - Investing.com Nigeria
Vivosim appoints Arumugham (Ragoo) Raghunathan as vice president of global sales - marketscreener.com
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewswire
VIVS Should I Buy - Intellectia AI
VIVS Technical Analysis & Stock Price Forecast - Intellectia AI
Exit Recap: Is VivoSim Labs Inc showing insider buying2025 Trading Volume Trends & Weekly Chart Analysis and Guides - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Travel Stocks: Does VivoSim Labs Inc have pricing powerJuly 2025 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
Vivosim Labs Inc Azioni (VIVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):